Monitoring the safety of COVID-19 vaccines in pregnancy in the US

References

• Centers for Disease Control and Prevention. Information about COVID-19 Vaccines for People who Are Pregnant or Breastfeeding. [accessed 2021 August 30] https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
   Google Scholar
• Centers for Disease Control and Prevention. Science Brief: evidence used to update the list of underlying medical conditions that increase a person’s risk of severe illness from COVID-19. Scientific Evidence for Conditions that Increase Risk of Severe Illness | COVID-19 | CDC.
   Google Scholar
• Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, Debenham L, Llavall AC, Dixit A, Zhou D, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi:10.1136/bmj.m3320.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): emergency use authorization (EUA) of the PfizerBioNTech COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). 2021. [Accessed 2021 August 30]. https://www.fda.gov/media/144413/download.
   Google Scholar
• Comirnaty (COVID-19 Vaccine, mRNA) FDA approval letter. [Accessed 2021 August 30]. https://www.fda.gov/media/151710/download.
   Google Scholar
• Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers): emergency use authorization (EUA) of the Moderna COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). 2021. [Accessed 2021 August 30]. https://www.fda.gov/media/144637/download
   Google Scholar
• Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers) emergency use authorization (EUA) of the Janssen COVID-19 vaccine to prevent coronavirus disease 2019 (COVID-19). 2021. [Accessed 2021 August 30]. https://www.fda.gov/media/146304/download.
   Google Scholar
• Taylor MM, Kobeissi L, Kim C, Amin A, Thorson AE, Bellare NB, Brizuela V, Bonet M, Kara E, Thwin SS, et al. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health. 2021;9(3):e366–e371. doi:10.1016/S2214-109X(20)30484-8.
   PubMed Web of Science ®Google Scholar
• Beigi RH, Krubiner C, Jamieson DJ, Lyerly AD, Hughes B, Riley L, Faden R, Karron R. The need for inclusion of pregnant women in COVID-19 vaccine trials. Vaccine. 2021;39(6):868–70. doi:10.1016/j.vaccine.2020.12.074.
   PubMed Web of Science ®Google Scholar
• Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine — United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1922–24. doi:10.15585/mmwr.mm6950e2.
   PubMed Web of Science ®Google Scholar
• Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine — United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1653–56. doi:10.15585/mmwr.mm695152e1.
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) Vaccines and Pregnancy: what Obstetricians Need to Know. Obstet Gynecol. 2021 Mar 1;137(3):408–14. doi:10.1097/AOG.0000000000004290.
   PubMed Web of Science ®Google Scholar
• Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398–405. doi:10.1016/j.vaccine.2015.07.035.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. V-safe COVID-19 Vaccine Pregnancy Registry. [Accessed 2021 August 30]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancyregistry.html.
   Google Scholar
• McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, et al. The vaccine safety datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014;32(42):5390–98. doi:10.1016/j.vaccine.2014.07.073.
   PubMed Web of Science ®Google Scholar
• Medical dictionary for regulatory activities. [Accessed 2021 August 30]. https://www.meddra.org/.
   Google Scholar
• 21 CFR Part 600.80. Postmarketing reporting of adverse experiences. Fed Regist 1997;7:52252–53.
   Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483–86. doi:10.1002/pds.677.
   PubMed Web of Science ®Google Scholar
• DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat. 1999;53:177–90.
   Web of Science ®Google Scholar
• Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25(6):381–92. doi:10.2165/00002018-200225060-00001.
   PubMed Web of Science ®Google Scholar
• Banks D, Woo EJ, Burwen DR, Perucci P, Braun MM, Ball R. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf. 2005;14(9):601–09. doi:10.1002/pds.1107.
   PubMed Web of Science ®Google Scholar
• Moro PL, Broder K, Zheteyeva Y, Revzina N, Tepper N, Kissin D, Barash F, Arana J, Brantley MD, Ding H, et al. Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol. 2011;205(5):473.e1–473.e9. doi:10.1016/j.ajog.2011.06.047.
   PubMed Web of Science ®Google Scholar
• Vsafe after vaccination health checker. [Accessed 2021 August 30]. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html.
   Google Scholar
• Vsafe pregnancy registry protocol. [Accessed 2021 August 30]. https://www.cdc.gov/vaccinesafety/pdf/V-safe-Protocol-508.pdf.
   Google Scholar
• Metropolitan Atlanta Congenital Defects Program (MACDP). [Accessed 2021 August 30]. https://www.cdc.gov/ncbddd/birthdefects/macdp.html.
   Google Scholar
• Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, Kharbanda EO, Irving S, Cheetham TC, McCarthy NL. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. Vaccine. 2013 Jun 12;31(27):2898–903. doi:10.1016/j.vaccine.2013.03.069.
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, DeSilva MB, Spaulding AB, Daley MF, Naleway AL, Irving SA, Klein NP, Tseng HF, Jackson LA et al. Developing algorithms for identifying major structural birth defects using automated electronic health data. Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):266–74. doi:10.1002/pds.5177.
   PubMed Web of Science ®Google Scholar
• Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C et al. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014 Feb;46(2):150–57. doi:10.1016/j.amepre.2013.10.010.
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Cheetham TC, Hambidge SJ, Vellozzi C, Nordin JD. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites. Prev Med. 2014 Oct;67:316–19. doi:10.1016/j.ypmed.2014.05.025.
   PubMed Web of Science ®Google Scholar
• Myers TR, McCarthy NL, Panagiotakopoulos L, Omer SB. Estimation of the Incidence of Guillain-Barré Syndrome During Pregnancy in the United States. Open Forum Infect Dis. 2019 Mar 15;6(3):ofz071. doi:10.1093/ofid/ofz071.
   PubMed Web of Science ®Google Scholar
• Vazquez-Benitez G, Kharbanda EO, Naleway AL, Lipkind H, Sukumaran L, McCarthy NL, Omer SB, Qian L, Xu S, Jackson ML et al. Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies. Am J Epidemiol. 2016 Aug 1;184(3):176–86. doi:10.1093/aje/kww043.
   PubMed Web of Science ®Google Scholar
• Razzaghi H, Meghani M, Pingali C, Crane B, Naleway A, Weintraub E, Kenigsberg TA, Lamias MJ, Irving SA, Kauffman TL, et al. COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021. MMWR Morb Mortal Wkly Rep. doi:10.15585/mmwr.mm7024e2externalicon.
   Web of Science ®Google Scholar
• Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, Marquez PL, Olson CK, Liu R, Chang KT, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021 Apr 21:NEJMoa2104983. doi:10.1056/NEJMoa2104983.
   PubMedGoogle Scholar